NCT00924027 2025-09-05A Study of Patients Receiving High-Dose Rate BrachytherapyNational Institutes of Health Clinical Center (CC)Phase 2 Completed43 enrolled 13 charts
NCT05712889 2024-11-15Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced CancerVincerx Pharma, Inc.Phase 1 Completed29 enrolled
NCT05074472 2024-01-29A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid TumorsZielBio, Inc.Phase 1/2 Completed35 enrolled